Author:
Dure-Smith B. A.,Kraenzlin M. E.,Farley S. M.,Libanati C. R.,Schulz E. E.,Baylink D. J.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference37 articles.
1. Farley JR, Wergedal JE, Baylink DJ (1983) Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science 222:330–332
2. Van Kesteren RG, Duursma SA, Visser WJ, van der Sluys V, Backer Dirks O (1982) Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium, and vitamin D. Metab Bone Dis Rel Res 4:31
3. Farley SM, Wergedal JE, Smith L, Lyndy MW, Farley JR, Baylink DJ (1987) Fluoride therapy for osteoporosis: characterisation of the skeletal response by serial measurements of serum alkaline phosphatase activity. Metabolism 36:211–218
4. Farley SMG, Perkel V, Tudtud-Hans LA, Mariano-Menez MR, Libanati CR, Schulz EE, Baylink DJ (1990) Fluoride and calcium therapy for osteoporosis increases trabecular vertebral bone density above the fracture threshold. In: DeLuca HF, Mazess R (eds) Osteoporosis: physiological basis, assessment and treatment. Elsevier, New York, pp 187–192
5. Riggs BL, Hodgson SF, Hoffman DL, Kelly PJ, Johnson KA, Taves D (1980) Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 243:446–449
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献